[HTML][HTML] Antidepressants and Social Functioning in Patients with Major Depressive Disorder: Systematic Review and Meta-Analysis of Double-Blind, Placebo …

S Kremer, T Wiesinger, T Bschor… - Psychotherapy and …, 2023 - karger.com
… as SMD (Cohen’s d) between drug and placebo arms and its 95% confidence interval as …
dose of a drug, we combined antidepressant arms to avoid double counting in placebo groups. …

[PDF][PDF] A CASE OF PERSISTENT DEPRESSIVE DISORDER WITH A SIGNIFICANT RESPONSE TO THE ADDITION OF LURASIDONE TO VORTIOXETINE

R Yoshimura, N Okamoto, S Hamada… - Psychiatria …, 2023 - psychiatria-danubina.com
… Among the chronic depressions called PDD, dysthymia is partic… Basically, dysthymia was
introduced as a diagnosis for major … In short, these is no robust evidence for drug treatment for …

[HTML][HTML] Unipolar major depression in adults: choosing initial treatment

AJ Rush - UpToDate www. uptodate. com/contents/unipolar …, 2023 - medilib.ir
placebo for six weeks; remission occurred in more patients who received active drug than
placebo (… the previously used diagnoses of dysthymic disorder and chronic major depression (…

Treatment of double depression: A meta-analysis

DG May, VN Shaffer, KL Yoon - Psychiatry Research, 2020 - Elsevier
… difficult to treat than either MDD or dysthymia alone. More research specifically focusing on
… Similarly, pharmacotherapy significantly outperformed placebo in a randomized controlled …

Gray matter reorganization underpinnings of antidepressant treatment of persistent depressive disorder

J Yang, DJ Hellerstein, Y Chen, PJ McGrath… - European …, 2021 - Elsevier
… We combined structural MRI scans from two placebo-… DSM-IV-TR diagnosis of dysthymic
disorder (DD) or depression NOS; … We attempted to minimize this possibility by increasing drug

Antipsychotic Monotherapy for Major Depressive Disorder: A Systematic Review and Meta-Analysis

A Nishi, K Sawada, H Uchida, M Mimura… - …, 2023 - thieme-connect.com
… arms comprising both APM and placebo arms. In studies involving both patients with MDD
and dysthymia, we included only those in which more than 50% of participants had MDD. …

[PDF][PDF] DYSTHYMIA AND ART OF RAPID PRESCRIBING

Y Gupta, S Sharma - researchgate.net
Dysthymia is a chronic depression of mood which does not currently fulfil the criteria for
recurrent depressive disorder, mild or moderate severity, duration of individual episodes …

Double trouble: Do symptom severity and duration interact to predicting treatment outcomes in adolescent depression?

L Lorenzo-Luaces, N Rodriguez-Quintana… - Behaviour Research and …, 2020 - Elsevier
… To our knowledge, no study has explored this question in a sample with a placebo control, …
However, these authors noted that all studies of SSRIs studied patients with dysthymia (ie, …

Efficacy and tolerability of combination treatments for major depression: antidepressants plus second-generation antipsychotics vs. esketamine vs. lithium

GH Vázquez, A Bahji, J Undurraga… - Journal of …, 2021 - journals.sagepub.com
… of patients responding to an active drug versus placebo. NNT indicates the approximate
number of … greater efficacy), typically based on response rates with a drug versus with placebo. …

Comparative remission rates and tolerability of drugs for generalised anxiety disorder: a systematic review and network meta-analysis of double-blind randomized …

W Kong, H Deng, J Wan, Y Zhou, Y Zhou… - Frontiers in …, 2020 - frontiersin.org
… Only one relevant RCT (including 191 patients) was included in the present analysis, and
in that trial lorazepam was not superior to placebo or other drugs with regard to remission, and …